AKT1 and breast carcinoma: The Akt1-E17K mutation existing in the PH domain has been observed frequently in breast carcinoma, ovarian carcinoma, and malignant meningioma with increased oncogenicity, particularly by facilitating AKT binding with PIP3, which promotes the action of AKT [51].